Clinical study on Yixiao Decoction in the treatment of type 2 diabetes complicated with left ventricular diastolic dysfunction

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1.Aged >40 and <75 years;
•2.Meet the diagnosis of type 2 diabetes;
•3.Meet the diagnosis of left ventricular diastolic dysfunction;
•4.Meet the TCM diagnosis of Qi and yin deficiency and blood stasis syndrome;
•5.Patients who are able to correctly describe their wishes, voluntarily fill in the informed consent form and agree to participate in clinical trials.

•1.Left ventricular ejection fraction < 50%;
•2.Patients with type 1 diabetes and other types of diabetes;
•3.Patients with rheumatic valvular heart disease, hypertrophic cardiomyopathy, dilated cardiomyopathy and other heart diseases have been definitely diagnosed;
•4.Patients with acute or severe complications of diabetes, such as ketoacidosis, hyperosmolar coma, infection, etc;
•5.Patients with chronic wasting diseases such as immune system diseases and malignant tumors;
•6.Patients with severe renal failure, liver coma and other visceral dysfunction, renal insufficiency requiring hemodialysis;
•7.Patients with severe electrolyte disorder and hematopathy;
•8.Patients with various mental diseases;
•9.Pregnant or lactating women, and women planning pregnancy or without contraception plan;
•10.Patients with diabetic retinopathy (proliferative stage) and hemorrhagic diseases;
•11.Patients known or suspected to be allergic to the drugs used in this study;
•12.Participants in other clinical trials within 3 months.

发起方

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine